Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
Author:
Affiliation:
1. Service d'hépato-gastroentérologie; Hôpital Saint-Louis; Université Paris VII; Paris France
2. Service d'Hépato-gastroentérologie - Univ. Bordeaux; Laboratoire de bactériologie; CHU de Bordeaux; Hôpital Haut-Lévêque; Pessac France
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12838/fullpdf
Reference81 articles.
1. The natural history of adult Crohn's disease in population-based cohorts;Peyrin-Biroulet;Am J Gastroenterol,2010
2. Development of the Crohn's disease digestive damage score, the Lémann score;Pariente;Inflamm Bowel Dis,2011
3. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change;Ordás;Gut,2011
4. Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases;Sandborn;J Crohns Colitis,2014
5. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease;Baert;Gastroenterology,2010
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Residual abnormalities on CTE predict adverse outcomes in Crohn's disease with endoscopic healing;Digestive and Liver Disease;2024-02
2. Immunomodulators after the discontinuation of anti‐tumor necrosis factor‐alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study;Journal of Gastroenterology and Hepatology;2023-10-12
3. Thiopurine Exposure During Pregnancy is Not Associated With Anemia in Infants Born to Mothers With IBD;Crohn's & Colitis 360;2023-10-01
4. Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years;Pharmaceuticals;2023-09-08
5. Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial;Journal of Crohn's and Colitis;2023-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3